Global Anti-thrombotic Drugs Market Growth 2026-2032
The global Anti-thrombotic Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
United States market for Anti-thrombotic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-thrombotic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-thrombotic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-thrombotic Drugs players cover Pfizer, Bayer, Johnson & Johnson, Boehringer Ingelheim Pharmaceuticals, Daiichi Sankyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Anti-thrombotic Drugs Industry Forecast” looks at past sales and reviews total world Anti-thrombotic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-thrombotic Drugs sales for 2026 through 2032. With Anti-thrombotic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-thrombotic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-thrombotic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-thrombotic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-thrombotic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-thrombotic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-thrombotic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-thrombotic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Anti-thrombotic Drugs market?
What factors are driving Anti-thrombotic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-thrombotic Drugs market opportunities vary by end market size?
How does Anti-thrombotic Drugs break out by Type, by Application?
United States market for Anti-thrombotic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Anti-thrombotic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Anti-thrombotic Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Anti-thrombotic Drugs players cover Pfizer, Bayer, Johnson & Johnson, Boehringer Ingelheim Pharmaceuticals, Daiichi Sankyo, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Anti-thrombotic Drugs Industry Forecast” looks at past sales and reviews total world Anti-thrombotic Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Anti-thrombotic Drugs sales for 2026 through 2032. With Anti-thrombotic Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-thrombotic Drugs industry.
This Insight Report provides a comprehensive analysis of the global Anti-thrombotic Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Anti-thrombotic Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-thrombotic Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-thrombotic Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-thrombotic Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-thrombotic Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Heparins
- Platelet Aggregation Inhibitors
- Enzymes
- Other
- Hospital
- Clinic
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- Bayer
- Johnson & Johnson
- Boehringer Ingelheim Pharmaceuticals
- Daiichi Sankyo
- Sanofi
- GlaxoSmithKline
- Bristol Myers Squibb
- Teva
- Sandoz
- Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
- Yantai Dongcheng North Pharmaceutical Co., Ltd.
- Tianjin Biochemical Pharmaceutical Co., Ltd.
- Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
- Tianjin Hongri Pharmaceutical Co., Ltd.
- Henan Yonghe Pharmaceutical Co., Ltd.
- Beijing Shuanglu Pharmaceutical Co., Ltd.
- Chengdu Baiyu Pharmaceutical Co., Ltd.
- Shandong Xinshidai Pharmaceutical Co., Ltd.
- Shandong Lvyin Pharmaceutical Co., Ltd.
- Shijiazhuang Heping Pharmaceutical Factory
- Sichuan Changzheng Pharmaceutical Co., Ltd.
- Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
- Beijing Chengji Pharmaceutical Co., Ltd.
- Beijing Taide Pharmaceutical Co., Ltd.
- Chengdu Yuandong Biopharmaceutical Co., Ltd.
- Chengdu Tongde Pharmaceutical Co., Ltd.
What is the 10-year outlook for the global Anti-thrombotic Drugs market?
What factors are driving Anti-thrombotic Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Anti-thrombotic Drugs market opportunities vary by end market size?
How does Anti-thrombotic Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-thrombotic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-thrombotic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-thrombotic Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-thrombotic Drugs Segment by Type
2.2.1 Heparins
2.2.2 Platelet Aggregation Inhibitors
2.2.3 Enzymes
2.2.4 Other
2.2.5 Anti-thrombotic Drugs Sales by Type
2.2.5.1 Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global Anti-thrombotic Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Anti-thrombotic Drugs Sale Price by Type (2021-2026)
2.3 Anti-thrombotic Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Anti-thrombotic Drugs Sales by Application
2.3.4.1 Global Anti-thrombotic Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Anti-thrombotic Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Anti-thrombotic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-thrombotic Drugs Breakdown Data by Company
3.1.1 Global Anti-thrombotic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-thrombotic Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-thrombotic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-thrombotic Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-thrombotic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-thrombotic Drugs Sale Price by Company
3.4 Key Manufacturers Anti-thrombotic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-thrombotic Drugs Product Location Distribution
3.4.2 Players Anti-thrombotic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-THROMBOTIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-thrombotic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-thrombotic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-thrombotic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-thrombotic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-thrombotic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-thrombotic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-thrombotic Drugs Sales Growth
4.4 APAC Anti-thrombotic Drugs Sales Growth
4.5 Europe Anti-thrombotic Drugs Sales Growth
4.6 Middle East & Africa Anti-thrombotic Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-thrombotic Drugs Sales by Country
5.1.1 Americas Anti-thrombotic Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-thrombotic Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-thrombotic Drugs Sales by Type (2021-2026)
5.3 Americas Anti-thrombotic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-thrombotic Drugs Sales by Region
6.1.1 APAC Anti-thrombotic Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-thrombotic Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-thrombotic Drugs Sales by Type (2021-2026)
6.3 APAC Anti-thrombotic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-thrombotic Drugs by Country
7.1.1 Europe Anti-thrombotic Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-thrombotic Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-thrombotic Drugs Sales by Type (2021-2026)
7.3 Europe Anti-thrombotic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-thrombotic Drugs by Country
8.1.1 Middle East & Africa Anti-thrombotic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-thrombotic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-thrombotic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-thrombotic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-thrombotic Drugs
10.3 Manufacturing Process Analysis of Anti-thrombotic Drugs
10.4 Industry Chain Structure of Anti-thrombotic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-thrombotic Drugs Distributors
11.3 Anti-thrombotic Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-THROMBOTIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-thrombotic Drugs Market Size Forecast by Region
12.1.1 Global Anti-thrombotic Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-thrombotic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-thrombotic Drugs Forecast by Type (2027-2032)
12.7 Global Anti-thrombotic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Anti-thrombotic Drugs Product Portfolios and Specifications
13.1.3 Pfizer Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Anti-thrombotic Drugs Product Portfolios and Specifications
13.2.3 Bayer Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Anti-thrombotic Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Boehringer Ingelheim Pharmaceuticals
13.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
13.4.2 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
13.4.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Anti-thrombotic Drugs Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi Anti-thrombotic Drugs Product Portfolios and Specifications
13.6.3 Sanofi Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Anti-thrombotic Drugs Product Portfolios and Specifications
13.7.3 GlaxoSmithKline Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Bristol Myers Squibb
13.8.1 Bristol Myers Squibb Company Information
13.8.2 Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolios and Specifications
13.8.3 Bristol Myers Squibb Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bristol Myers Squibb Main Business Overview
13.8.5 Bristol Myers Squibb Latest Developments
13.9 Teva
13.9.1 Teva Company Information
13.9.2 Teva Anti-thrombotic Drugs Product Portfolios and Specifications
13.9.3 Teva Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Main Business Overview
13.9.5 Teva Latest Developments
13.10 Sandoz
13.10.1 Sandoz Company Information
13.10.2 Sandoz Anti-thrombotic Drugs Product Portfolios and Specifications
13.10.3 Sandoz Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sandoz Main Business Overview
13.10.5 Sandoz Latest Developments
13.11 Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
13.11.1 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
13.11.2 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.11.3 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Latest Developments
13.12 Yantai Dongcheng North Pharmaceutical Co., Ltd.
13.12.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
13.12.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.12.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Latest Developments
13.13 Tianjin Biochemical Pharmaceutical Co., Ltd.
13.13.1 Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
13.13.2 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.13.3 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Tianjin Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Tianjin Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.14 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
13.14.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
13.14.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.14.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.15 Tianjin Hongri Pharmaceutical Co., Ltd.
13.15.1 Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
13.15.2 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.15.3 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Tianjin Hongri Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Tianjin Hongri Pharmaceutical Co., Ltd. Latest Developments
13.16 Henan Yonghe Pharmaceutical Co., Ltd.
13.16.1 Henan Yonghe Pharmaceutical Co., Ltd. Company Information
13.16.2 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.16.3 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Henan Yonghe Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Henan Yonghe Pharmaceutical Co., Ltd. Latest Developments
13.17 Beijing Shuanglu Pharmaceutical Co., Ltd.
13.17.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
13.17.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.17.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Latest Developments
13.18 Chengdu Baiyu Pharmaceutical Co., Ltd.
13.18.1 Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
13.18.2 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.18.3 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Chengdu Baiyu Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Chengdu Baiyu Pharmaceutical Co., Ltd. Latest Developments
13.19 Shandong Xinshidai Pharmaceutical Co., Ltd.
13.19.1 Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
13.19.2 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.19.3 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shandong Xinshidai Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Shandong Xinshidai Pharmaceutical Co., Ltd. Latest Developments
13.20 Shandong Lvyin Pharmaceutical Co., Ltd.
13.20.1 Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
13.20.2 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.20.3 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Shandong Lvyin Pharmaceutical Co., Ltd. Main Business Overview
13.20.5 Shandong Lvyin Pharmaceutical Co., Ltd. Latest Developments
13.21 Shijiazhuang Heping Pharmaceutical Factory
13.21.1 Shijiazhuang Heping Pharmaceutical Factory Company Information
13.21.2 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolios and Specifications
13.21.3 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Shijiazhuang Heping Pharmaceutical Factory Main Business Overview
13.21.5 Shijiazhuang Heping Pharmaceutical Factory Latest Developments
13.22 Sichuan Changzheng Pharmaceutical Co., Ltd.
13.22.1 Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
13.22.2 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.22.3 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Sichuan Changzheng Pharmaceutical Co., Ltd. Main Business Overview
13.22.5 Sichuan Changzheng Pharmaceutical Co., Ltd. Latest Developments
13.23 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
13.23.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
13.23.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.23.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.23.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.24 Beijing Chengji Pharmaceutical Co., Ltd.
13.24.1 Beijing Chengji Pharmaceutical Co., Ltd. Company Information
13.24.2 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.24.3 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Beijing Chengji Pharmaceutical Co., Ltd. Main Business Overview
13.24.5 Beijing Chengji Pharmaceutical Co., Ltd. Latest Developments
13.25 Beijing Taide Pharmaceutical Co., Ltd.
13.25.1 Beijing Taide Pharmaceutical Co., Ltd. Company Information
13.25.2 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.25.3 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Beijing Taide Pharmaceutical Co., Ltd. Main Business Overview
13.25.5 Beijing Taide Pharmaceutical Co., Ltd. Latest Developments
13.26 Chengdu Yuandong Biopharmaceutical Co., Ltd.
13.26.1 Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
13.26.2 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.26.3 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Chengdu Yuandong Biopharmaceutical Co., Ltd. Main Business Overview
13.26.5 Chengdu Yuandong Biopharmaceutical Co., Ltd. Latest Developments
13.27 Chengdu Tongde Pharmaceutical Co., Ltd.
13.27.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
13.27.2 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.27.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Chengdu Tongde Pharmaceutical Co., Ltd. Main Business Overview
13.27.5 Chengdu Tongde Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Anti-thrombotic Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Anti-thrombotic Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Anti-thrombotic Drugs by Country/Region, 2021, 2025 & 2032
2.2 Anti-thrombotic Drugs Segment by Type
2.2.1 Heparins
2.2.2 Platelet Aggregation Inhibitors
2.2.3 Enzymes
2.2.4 Other
2.2.5 Anti-thrombotic Drugs Sales by Type
2.2.5.1 Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
2.2.5.2 Global Anti-thrombotic Drugs Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Anti-thrombotic Drugs Sale Price by Type (2021-2026)
2.3 Anti-thrombotic Drugs Segment by Application
2.3.1 Hospital
2.3.2 Clinic
2.3.3 Other
2.3.4 Anti-thrombotic Drugs Sales by Application
2.3.4.1 Global Anti-thrombotic Drugs Sale Market Share by Application (2021-2026)
2.3.4.2 Global Anti-thrombotic Drugs Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Anti-thrombotic Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Anti-thrombotic Drugs Breakdown Data by Company
3.1.1 Global Anti-thrombotic Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Anti-thrombotic Drugs Sales Market Share by Company (2021-2026)
3.2 Global Anti-thrombotic Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Anti-thrombotic Drugs Revenue by Company (2021-2026)
3.2.2 Global Anti-thrombotic Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Anti-thrombotic Drugs Sale Price by Company
3.4 Key Manufacturers Anti-thrombotic Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Anti-thrombotic Drugs Product Location Distribution
3.4.2 Players Anti-thrombotic Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR ANTI-THROMBOTIC DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Anti-thrombotic Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Anti-thrombotic Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Anti-thrombotic Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Anti-thrombotic Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Anti-thrombotic Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Anti-thrombotic Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Anti-thrombotic Drugs Sales Growth
4.4 APAC Anti-thrombotic Drugs Sales Growth
4.5 Europe Anti-thrombotic Drugs Sales Growth
4.6 Middle East & Africa Anti-thrombotic Drugs Sales Growth
5 AMERICAS
5.1 Americas Anti-thrombotic Drugs Sales by Country
5.1.1 Americas Anti-thrombotic Drugs Sales by Country (2021-2026)
5.1.2 Americas Anti-thrombotic Drugs Revenue by Country (2021-2026)
5.2 Americas Anti-thrombotic Drugs Sales by Type (2021-2026)
5.3 Americas Anti-thrombotic Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-thrombotic Drugs Sales by Region
6.1.1 APAC Anti-thrombotic Drugs Sales by Region (2021-2026)
6.1.2 APAC Anti-thrombotic Drugs Revenue by Region (2021-2026)
6.2 APAC Anti-thrombotic Drugs Sales by Type (2021-2026)
6.3 APAC Anti-thrombotic Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Anti-thrombotic Drugs by Country
7.1.1 Europe Anti-thrombotic Drugs Sales by Country (2021-2026)
7.1.2 Europe Anti-thrombotic Drugs Revenue by Country (2021-2026)
7.2 Europe Anti-thrombotic Drugs Sales by Type (2021-2026)
7.3 Europe Anti-thrombotic Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Anti-thrombotic Drugs by Country
8.1.1 Middle East & Africa Anti-thrombotic Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Anti-thrombotic Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Anti-thrombotic Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Anti-thrombotic Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Anti-thrombotic Drugs
10.3 Manufacturing Process Analysis of Anti-thrombotic Drugs
10.4 Industry Chain Structure of Anti-thrombotic Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Anti-thrombotic Drugs Distributors
11.3 Anti-thrombotic Drugs Customer
12 WORLD FORECAST REVIEW FOR ANTI-THROMBOTIC DRUGS BY GEOGRAPHIC REGION
12.1 Global Anti-thrombotic Drugs Market Size Forecast by Region
12.1.1 Global Anti-thrombotic Drugs Forecast by Region (2027-2032)
12.1.2 Global Anti-thrombotic Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Anti-thrombotic Drugs Forecast by Type (2027-2032)
12.7 Global Anti-thrombotic Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Anti-thrombotic Drugs Product Portfolios and Specifications
13.1.3 Pfizer Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Bayer
13.2.1 Bayer Company Information
13.2.2 Bayer Anti-thrombotic Drugs Product Portfolios and Specifications
13.2.3 Bayer Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Bayer Main Business Overview
13.2.5 Bayer Latest Developments
13.3 Johnson & Johnson
13.3.1 Johnson & Johnson Company Information
13.3.2 Johnson & Johnson Anti-thrombotic Drugs Product Portfolios and Specifications
13.3.3 Johnson & Johnson Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Johnson & Johnson Main Business Overview
13.3.5 Johnson & Johnson Latest Developments
13.4 Boehringer Ingelheim Pharmaceuticals
13.4.1 Boehringer Ingelheim Pharmaceuticals Company Information
13.4.2 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolios and Specifications
13.4.3 Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Boehringer Ingelheim Pharmaceuticals Main Business Overview
13.4.5 Boehringer Ingelheim Pharmaceuticals Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Anti-thrombotic Drugs Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Sanofi
13.6.1 Sanofi Company Information
13.6.2 Sanofi Anti-thrombotic Drugs Product Portfolios and Specifications
13.6.3 Sanofi Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sanofi Main Business Overview
13.6.5 Sanofi Latest Developments
13.7 GlaxoSmithKline
13.7.1 GlaxoSmithKline Company Information
13.7.2 GlaxoSmithKline Anti-thrombotic Drugs Product Portfolios and Specifications
13.7.3 GlaxoSmithKline Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 GlaxoSmithKline Main Business Overview
13.7.5 GlaxoSmithKline Latest Developments
13.8 Bristol Myers Squibb
13.8.1 Bristol Myers Squibb Company Information
13.8.2 Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolios and Specifications
13.8.3 Bristol Myers Squibb Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Bristol Myers Squibb Main Business Overview
13.8.5 Bristol Myers Squibb Latest Developments
13.9 Teva
13.9.1 Teva Company Information
13.9.2 Teva Anti-thrombotic Drugs Product Portfolios and Specifications
13.9.3 Teva Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Teva Main Business Overview
13.9.5 Teva Latest Developments
13.10 Sandoz
13.10.1 Sandoz Company Information
13.10.2 Sandoz Anti-thrombotic Drugs Product Portfolios and Specifications
13.10.3 Sandoz Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Sandoz Main Business Overview
13.10.5 Sandoz Latest Developments
13.11 Shenzhen Saibaoer Biopharmaceutical Co., Ltd.
13.11.1 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Company Information
13.11.2 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.11.3 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Main Business Overview
13.11.5 Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Latest Developments
13.12 Yantai Dongcheng North Pharmaceutical Co., Ltd.
13.12.1 Yantai Dongcheng North Pharmaceutical Co., Ltd. Company Information
13.12.2 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.12.3 Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Yantai Dongcheng North Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Yantai Dongcheng North Pharmaceutical Co., Ltd. Latest Developments
13.13 Tianjin Biochemical Pharmaceutical Co., Ltd.
13.13.1 Tianjin Biochemical Pharmaceutical Co., Ltd. Company Information
13.13.2 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.13.3 Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Tianjin Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Tianjin Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.14 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd.
13.14.1 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Company Information
13.14.2 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.14.3 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.15 Tianjin Hongri Pharmaceutical Co., Ltd.
13.15.1 Tianjin Hongri Pharmaceutical Co., Ltd. Company Information
13.15.2 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.15.3 Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Tianjin Hongri Pharmaceutical Co., Ltd. Main Business Overview
13.15.5 Tianjin Hongri Pharmaceutical Co., Ltd. Latest Developments
13.16 Henan Yonghe Pharmaceutical Co., Ltd.
13.16.1 Henan Yonghe Pharmaceutical Co., Ltd. Company Information
13.16.2 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.16.3 Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Henan Yonghe Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Henan Yonghe Pharmaceutical Co., Ltd. Latest Developments
13.17 Beijing Shuanglu Pharmaceutical Co., Ltd.
13.17.1 Beijing Shuanglu Pharmaceutical Co., Ltd. Company Information
13.17.2 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.17.3 Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Beijing Shuanglu Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 Beijing Shuanglu Pharmaceutical Co., Ltd. Latest Developments
13.18 Chengdu Baiyu Pharmaceutical Co., Ltd.
13.18.1 Chengdu Baiyu Pharmaceutical Co., Ltd. Company Information
13.18.2 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.18.3 Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Chengdu Baiyu Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Chengdu Baiyu Pharmaceutical Co., Ltd. Latest Developments
13.19 Shandong Xinshidai Pharmaceutical Co., Ltd.
13.19.1 Shandong Xinshidai Pharmaceutical Co., Ltd. Company Information
13.19.2 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.19.3 Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 Shandong Xinshidai Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Shandong Xinshidai Pharmaceutical Co., Ltd. Latest Developments
13.20 Shandong Lvyin Pharmaceutical Co., Ltd.
13.20.1 Shandong Lvyin Pharmaceutical Co., Ltd. Company Information
13.20.2 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.20.3 Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.20.4 Shandong Lvyin Pharmaceutical Co., Ltd. Main Business Overview
13.20.5 Shandong Lvyin Pharmaceutical Co., Ltd. Latest Developments
13.21 Shijiazhuang Heping Pharmaceutical Factory
13.21.1 Shijiazhuang Heping Pharmaceutical Factory Company Information
13.21.2 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolios and Specifications
13.21.3 Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.21.4 Shijiazhuang Heping Pharmaceutical Factory Main Business Overview
13.21.5 Shijiazhuang Heping Pharmaceutical Factory Latest Developments
13.22 Sichuan Changzheng Pharmaceutical Co., Ltd.
13.22.1 Sichuan Changzheng Pharmaceutical Co., Ltd. Company Information
13.22.2 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.22.3 Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.22.4 Sichuan Changzheng Pharmaceutical Co., Ltd. Main Business Overview
13.22.5 Sichuan Changzheng Pharmaceutical Co., Ltd. Latest Developments
13.23 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd.
13.23.1 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Company Information
13.23.2 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.23.3 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.23.4 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business Overview
13.23.5 Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
13.24 Beijing Chengji Pharmaceutical Co., Ltd.
13.24.1 Beijing Chengji Pharmaceutical Co., Ltd. Company Information
13.24.2 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.24.3 Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.24.4 Beijing Chengji Pharmaceutical Co., Ltd. Main Business Overview
13.24.5 Beijing Chengji Pharmaceutical Co., Ltd. Latest Developments
13.25 Beijing Taide Pharmaceutical Co., Ltd.
13.25.1 Beijing Taide Pharmaceutical Co., Ltd. Company Information
13.25.2 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.25.3 Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.25.4 Beijing Taide Pharmaceutical Co., Ltd. Main Business Overview
13.25.5 Beijing Taide Pharmaceutical Co., Ltd. Latest Developments
13.26 Chengdu Yuandong Biopharmaceutical Co., Ltd.
13.26.1 Chengdu Yuandong Biopharmaceutical Co., Ltd. Company Information
13.26.2 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.26.3 Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.26.4 Chengdu Yuandong Biopharmaceutical Co., Ltd. Main Business Overview
13.26.5 Chengdu Yuandong Biopharmaceutical Co., Ltd. Latest Developments
13.27 Chengdu Tongde Pharmaceutical Co., Ltd.
13.27.1 Chengdu Tongde Pharmaceutical Co., Ltd. Company Information
13.27.2 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
13.27.3 Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.27.4 Chengdu Tongde Pharmaceutical Co., Ltd. Main Business Overview
13.27.5 Chengdu Tongde Pharmaceutical Co., Ltd. Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Anti-thrombotic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-thrombotic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heparins
Table 4. Major Players of Platelet Aggregation Inhibitors
Table 5. Major Players of Enzymes
Table 6. Major Players of Other
Table 7. Global Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Table 9. Global Anti-thrombotic Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global Anti-thrombotic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Anti-thrombotic Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global Anti-thrombotic Drugs Sale Market Share by Application (2021-2026)
Table 14. Global Anti-thrombotic Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global Anti-thrombotic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Anti-thrombotic Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global Anti-thrombotic Drugs Sales Market Share by Company (2021-2026)
Table 19. Global Anti-thrombotic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Anti-thrombotic Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global Anti-thrombotic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Anti-thrombotic Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-thrombotic Drugs Products Offered
Table 24. Anti-thrombotic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-thrombotic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Anti-thrombotic Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global Anti-thrombotic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Anti-thrombotic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Anti-thrombotic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Anti-thrombotic Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global Anti-thrombotic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Anti-thrombotic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas Anti-thrombotic Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas Anti-thrombotic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC Anti-thrombotic Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC Anti-thrombotic Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC Anti-thrombotic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe Anti-thrombotic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-thrombotic Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-thrombotic Drugs
Table 54. Key Market Challenges & Risks of Anti-thrombotic Drugs
Table 55. Key Industry Trends of Anti-thrombotic Drugs
Table 56. Anti-thrombotic Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-thrombotic Drugs Distributors List
Table 59. Anti-thrombotic Drugs Customer List
Table 60. Global Anti-thrombotic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Anti-thrombotic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Anti-thrombotic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Anti-thrombotic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Anti-thrombotic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Anti-thrombotic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Anti-thrombotic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Anti-thrombotic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Anti-thrombotic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Anti-thrombotic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Anti-thrombotic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Anti-thrombotic Drugs Product Portfolios and Specifications
Table 76. Pfizer Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Bayer Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Bayer Anti-thrombotic Drugs Product Portfolios and Specifications
Table 81. Bayer Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Bayer Main Business
Table 83. Bayer Latest Developments
Table 84. Johnson & Johnson Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & Johnson Anti-thrombotic Drugs Product Portfolios and Specifications
Table 86. Johnson & Johnson Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89. Boehringer Ingelheim Pharmaceuticals Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Boehringer Ingelheim Pharmaceuticals Main Business
Table 93. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 94. Daiichi Sankyo Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Daiichi Sankyo Anti-thrombotic Drugs Product Portfolios and Specifications
Table 96. Daiichi Sankyo Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Daiichi Sankyo Main Business
Table 98. Daiichi Sankyo Latest Developments
Table 99. Sanofi Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Anti-thrombotic Drugs Product Portfolios and Specifications
Table 101. Sanofi Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. GlaxoSmithKline Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. GlaxoSmithKline Anti-thrombotic Drugs Product Portfolios and Specifications
Table 106. GlaxoSmithKline Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. GlaxoSmithKline Main Business
Table 108. GlaxoSmithKline Latest Developments
Table 109. Bristol Myers Squibb Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolios and Specifications
Table 111. Bristol Myers Squibb Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bristol Myers Squibb Main Business
Table 113. Bristol Myers Squibb Latest Developments
Table 114. Teva Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Teva Anti-thrombotic Drugs Product Portfolios and Specifications
Table 116. Teva Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Teva Main Business
Table 118. Teva Latest Developments
Table 119. Sandoz Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Sandoz Anti-thrombotic Drugs Product Portfolios and Specifications
Table 121. Sandoz Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Sandoz Main Business
Table 123. Sandoz Latest Developments
Table 124. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 126. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Main Business
Table 128. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Latest Developments
Table 129. Yantai Dongcheng North Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 131. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Yantai Dongcheng North Pharmaceutical Co., Ltd. Main Business
Table 133. Yantai Dongcheng North Pharmaceutical Co., Ltd. Latest Developments
Table 134. Tianjin Biochemical Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 136. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Tianjin Biochemical Pharmaceutical Co., Ltd. Main Business
Table 138. Tianjin Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 139. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 141. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business
Table 143. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 144. Tianjin Hongri Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 146. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Tianjin Hongri Pharmaceutical Co., Ltd. Main Business
Table 148. Tianjin Hongri Pharmaceutical Co., Ltd. Latest Developments
Table 149. Henan Yonghe Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 151. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Henan Yonghe Pharmaceutical Co., Ltd. Main Business
Table 153. Henan Yonghe Pharmaceutical Co., Ltd. Latest Developments
Table 154. Beijing Shuanglu Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 156. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Beijing Shuanglu Pharmaceutical Co., Ltd. Main Business
Table 158. Beijing Shuanglu Pharmaceutical Co., Ltd. Latest Developments
Table 159. Chengdu Baiyu Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 161. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Chengdu Baiyu Pharmaceutical Co., Ltd. Main Business
Table 163. Chengdu Baiyu Pharmaceutical Co., Ltd. Latest Developments
Table 164. Shandong Xinshidai Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 165. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 166. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Shandong Xinshidai Pharmaceutical Co., Ltd. Main Business
Table 168. Shandong Xinshidai Pharmaceutical Co., Ltd. Latest Developments
Table 169. Shandong Lvyin Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 170. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 171. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Shandong Lvyin Pharmaceutical Co., Ltd. Main Business
Table 173. Shandong Lvyin Pharmaceutical Co., Ltd. Latest Developments
Table 174. Shijiazhuang Heping Pharmaceutical Factory Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 175. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolios and Specifications
Table 176. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Shijiazhuang Heping Pharmaceutical Factory Main Business
Table 178. Shijiazhuang Heping Pharmaceutical Factory Latest Developments
Table 179. Sichuan Changzheng Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 180. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 181. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Sichuan Changzheng Pharmaceutical Co., Ltd. Main Business
Table 183. Sichuan Changzheng Pharmaceutical Co., Ltd. Latest Developments
Table 184. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 185. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 186. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business
Table 188. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 189. Beijing Chengji Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 190. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 191. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Beijing Chengji Pharmaceutical Co., Ltd. Main Business
Table 193. Beijing Chengji Pharmaceutical Co., Ltd. Latest Developments
Table 194. Beijing Taide Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 195. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 196. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Beijing Taide Pharmaceutical Co., Ltd. Main Business
Table 198. Beijing Taide Pharmaceutical Co., Ltd. Latest Developments
Table 199. Chengdu Yuandong Biopharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 200. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 201. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Chengdu Yuandong Biopharmaceutical Co., Ltd. Main Business
Table 203. Chengdu Yuandong Biopharmaceutical Co., Ltd. Latest Developments
Table 204. Chengdu Tongde Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 205. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 206. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Chengdu Tongde Pharmaceutical Co., Ltd. Main Business
Table 208. Chengdu Tongde Pharmaceutical Co., Ltd. Latest Developments
Table 1. Anti-thrombotic Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Anti-thrombotic Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Heparins
Table 4. Major Players of Platelet Aggregation Inhibitors
Table 5. Major Players of Enzymes
Table 6. Major Players of Other
Table 7. Global Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 8. Global Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Table 9. Global Anti-thrombotic Drugs Revenue by Type (2021-2026) & ($ million)
Table 10. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2026)
Table 11. Global Anti-thrombotic Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Global Anti-thrombotic Drugs Sale by Application (2021-2026) & (K Units)
Table 13. Global Anti-thrombotic Drugs Sale Market Share by Application (2021-2026)
Table 14. Global Anti-thrombotic Drugs Revenue by Application (2021-2026) & ($ million)
Table 15. Global Anti-thrombotic Drugs Revenue Market Share by Application (2021-2026)
Table 16. Global Anti-thrombotic Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 17. Global Anti-thrombotic Drugs Sales by Company (2021-2026) & (K Units)
Table 18. Global Anti-thrombotic Drugs Sales Market Share by Company (2021-2026)
Table 19. Global Anti-thrombotic Drugs Revenue by Company (2021-2026) & ($ millions)
Table 20. Global Anti-thrombotic Drugs Revenue Market Share by Company (2021-2026)
Table 21. Global Anti-thrombotic Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 22. Key Manufacturers Anti-thrombotic Drugs Producing Area Distribution and Sales Area
Table 23. Players Anti-thrombotic Drugs Products Offered
Table 24. Anti-thrombotic Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 25. New Products and Potential Entrants
Table 26. Market M&A Activity & Strategy
Table 27. Global Anti-thrombotic Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 28. Global Anti-thrombotic Drugs Sales Market Share Geographic Region (2021-2026)
Table 29. Global Anti-thrombotic Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 30. Global Anti-thrombotic Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 31. Global Anti-thrombotic Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 32. Global Anti-thrombotic Drugs Sales Market Share by Country/Region (2021-2026)
Table 33. Global Anti-thrombotic Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 34. Global Anti-thrombotic Drugs Revenue Market Share by Country/Region (2021-2026)
Table 35. Americas Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 36. Americas Anti-thrombotic Drugs Sales Market Share by Country (2021-2026)
Table 37. Americas Anti-thrombotic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 38. Americas Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 39. Americas Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 40. APAC Anti-thrombotic Drugs Sales by Region (2021-2026) & (K Units)
Table 41. APAC Anti-thrombotic Drugs Sales Market Share by Region (2021-2026)
Table 42. APAC Anti-thrombotic Drugs Revenue by Region (2021-2026) & ($ millions)
Table 43. APAC Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 44. APAC Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 45. Europe Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 46. Europe Anti-thrombotic Drugs Revenue by Country (2021-2026) & ($ millions)
Table 47. Europe Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 48. Europe Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 49. Middle East & Africa Anti-thrombotic Drugs Sales by Country (2021-2026) & (K Units)
Table 50. Middle East & Africa Anti-thrombotic Drugs Revenue Market Share by Country (2021-2026)
Table 51. Middle East & Africa Anti-thrombotic Drugs Sales by Type (2021-2026) & (K Units)
Table 52. Middle East & Africa Anti-thrombotic Drugs Sales by Application (2021-2026) & (K Units)
Table 53. Key Market Drivers & Growth Opportunities of Anti-thrombotic Drugs
Table 54. Key Market Challenges & Risks of Anti-thrombotic Drugs
Table 55. Key Industry Trends of Anti-thrombotic Drugs
Table 56. Anti-thrombotic Drugs Raw Material
Table 57. Key Suppliers of Raw Materials
Table 58. Anti-thrombotic Drugs Distributors List
Table 59. Anti-thrombotic Drugs Customer List
Table 60. Global Anti-thrombotic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 61. Global Anti-thrombotic Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 62. Americas Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 63. Americas Anti-thrombotic Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 64. APAC Anti-thrombotic Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 65. APAC Anti-thrombotic Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 66. Europe Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 67. Europe Anti-thrombotic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Middle East & Africa Anti-thrombotic Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 69. Middle East & Africa Anti-thrombotic Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 70. Global Anti-thrombotic Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 71. Global Anti-thrombotic Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 72. Global Anti-thrombotic Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 73. Global Anti-thrombotic Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 74. Pfizer Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 75. Pfizer Anti-thrombotic Drugs Product Portfolios and Specifications
Table 76. Pfizer Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 77. Pfizer Main Business
Table 78. Pfizer Latest Developments
Table 79. Bayer Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 80. Bayer Anti-thrombotic Drugs Product Portfolios and Specifications
Table 81. Bayer Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 82. Bayer Main Business
Table 83. Bayer Latest Developments
Table 84. Johnson & Johnson Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 85. Johnson & Johnson Anti-thrombotic Drugs Product Portfolios and Specifications
Table 86. Johnson & Johnson Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 87. Johnson & Johnson Main Business
Table 88. Johnson & Johnson Latest Developments
Table 89. Boehringer Ingelheim Pharmaceuticals Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 90. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Product Portfolios and Specifications
Table 91. Boehringer Ingelheim Pharmaceuticals Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 92. Boehringer Ingelheim Pharmaceuticals Main Business
Table 93. Boehringer Ingelheim Pharmaceuticals Latest Developments
Table 94. Daiichi Sankyo Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 95. Daiichi Sankyo Anti-thrombotic Drugs Product Portfolios and Specifications
Table 96. Daiichi Sankyo Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 97. Daiichi Sankyo Main Business
Table 98. Daiichi Sankyo Latest Developments
Table 99. Sanofi Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 100. Sanofi Anti-thrombotic Drugs Product Portfolios and Specifications
Table 101. Sanofi Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 102. Sanofi Main Business
Table 103. Sanofi Latest Developments
Table 104. GlaxoSmithKline Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 105. GlaxoSmithKline Anti-thrombotic Drugs Product Portfolios and Specifications
Table 106. GlaxoSmithKline Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 107. GlaxoSmithKline Main Business
Table 108. GlaxoSmithKline Latest Developments
Table 109. Bristol Myers Squibb Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 110. Bristol Myers Squibb Anti-thrombotic Drugs Product Portfolios and Specifications
Table 111. Bristol Myers Squibb Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. Bristol Myers Squibb Main Business
Table 113. Bristol Myers Squibb Latest Developments
Table 114. Teva Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 115. Teva Anti-thrombotic Drugs Product Portfolios and Specifications
Table 116. Teva Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Teva Main Business
Table 118. Teva Latest Developments
Table 119. Sandoz Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 120. Sandoz Anti-thrombotic Drugs Product Portfolios and Specifications
Table 121. Sandoz Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Sandoz Main Business
Table 123. Sandoz Latest Developments
Table 124. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 125. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 126. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Main Business
Table 128. Shenzhen Saibaoer Biopharmaceutical Co., Ltd. Latest Developments
Table 129. Yantai Dongcheng North Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 130. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 131. Yantai Dongcheng North Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Yantai Dongcheng North Pharmaceutical Co., Ltd. Main Business
Table 133. Yantai Dongcheng North Pharmaceutical Co., Ltd. Latest Developments
Table 134. Tianjin Biochemical Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 135. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 136. Tianjin Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. Tianjin Biochemical Pharmaceutical Co., Ltd. Main Business
Table 138. Tianjin Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 139. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 140. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 141. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Main Business
Table 143. Changzhou Qianhong Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 144. Tianjin Hongri Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 145. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 146. Tianjin Hongri Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Tianjin Hongri Pharmaceutical Co., Ltd. Main Business
Table 148. Tianjin Hongri Pharmaceutical Co., Ltd. Latest Developments
Table 149. Henan Yonghe Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 150. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 151. Henan Yonghe Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Henan Yonghe Pharmaceutical Co., Ltd. Main Business
Table 153. Henan Yonghe Pharmaceutical Co., Ltd. Latest Developments
Table 154. Beijing Shuanglu Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 155. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 156. Beijing Shuanglu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Beijing Shuanglu Pharmaceutical Co., Ltd. Main Business
Table 158. Beijing Shuanglu Pharmaceutical Co., Ltd. Latest Developments
Table 159. Chengdu Baiyu Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 160. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 161. Chengdu Baiyu Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. Chengdu Baiyu Pharmaceutical Co., Ltd. Main Business
Table 163. Chengdu Baiyu Pharmaceutical Co., Ltd. Latest Developments
Table 164. Shandong Xinshidai Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 165. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 166. Shandong Xinshidai Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 167. Shandong Xinshidai Pharmaceutical Co., Ltd. Main Business
Table 168. Shandong Xinshidai Pharmaceutical Co., Ltd. Latest Developments
Table 169. Shandong Lvyin Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 170. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 171. Shandong Lvyin Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 172. Shandong Lvyin Pharmaceutical Co., Ltd. Main Business
Table 173. Shandong Lvyin Pharmaceutical Co., Ltd. Latest Developments
Table 174. Shijiazhuang Heping Pharmaceutical Factory Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 175. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Product Portfolios and Specifications
Table 176. Shijiazhuang Heping Pharmaceutical Factory Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 177. Shijiazhuang Heping Pharmaceutical Factory Main Business
Table 178. Shijiazhuang Heping Pharmaceutical Factory Latest Developments
Table 179. Sichuan Changzheng Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 180. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 181. Sichuan Changzheng Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 182. Sichuan Changzheng Pharmaceutical Co., Ltd. Main Business
Table 183. Sichuan Changzheng Pharmaceutical Co., Ltd. Latest Developments
Table 184. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 185. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 186. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 187. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Main Business
Table 188. Nanjing Jianyou Biochemical Pharmaceutical Co., Ltd. Latest Developments
Table 189. Beijing Chengji Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 190. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 191. Beijing Chengji Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 192. Beijing Chengji Pharmaceutical Co., Ltd. Main Business
Table 193. Beijing Chengji Pharmaceutical Co., Ltd. Latest Developments
Table 194. Beijing Taide Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 195. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 196. Beijing Taide Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 197. Beijing Taide Pharmaceutical Co., Ltd. Main Business
Table 198. Beijing Taide Pharmaceutical Co., Ltd. Latest Developments
Table 199. Chengdu Yuandong Biopharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 200. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 201. Chengdu Yuandong Biopharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 202. Chengdu Yuandong Biopharmaceutical Co., Ltd. Main Business
Table 203. Chengdu Yuandong Biopharmaceutical Co., Ltd. Latest Developments
Table 204. Chengdu Tongde Pharmaceutical Co., Ltd. Basic Information, Anti-thrombotic Drugs Manufacturing Base, Sales Area and Its Competitors
Table 205. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Product Portfolios and Specifications
Table 206. Chengdu Tongde Pharmaceutical Co., Ltd. Anti-thrombotic Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 207. Chengdu Tongde Pharmaceutical Co., Ltd. Main Business
Table 208. Chengdu Tongde Pharmaceutical Co., Ltd. Latest Developments
LIST OF FIGURES
Figure 1. Picture of Anti-thrombotic Drugs
Figure 2. Anti-thrombotic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-thrombotic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-thrombotic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-thrombotic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-thrombotic Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-thrombotic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Heparins
Figure 12. Product Picture of Platelet Aggregation Inhibitors
Figure 13. Product Picture of Enzymes
Figure 14. Product Picture of Other
Figure 15. Global Anti-thrombotic Drugs Sales Market Share by Type in 2026
Figure 16. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Anti-thrombotic Drugs Consumed in Hospital
Figure 18. Global Anti-thrombotic Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. Anti-thrombotic Drugs Consumed in Clinic
Figure 20. Global Anti-thrombotic Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. Anti-thrombotic Drugs Consumed in Other
Figure 22. Global Anti-thrombotic Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Anti-thrombotic Drugs Sale Market Share by Application (2025)
Figure 24. Global Anti-thrombotic Drugs Revenue Market Share by Application in 2026
Figure 25. Anti-thrombotic Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Anti-thrombotic Drugs Sales Market Share by Company in 2026
Figure 27. Anti-thrombotic Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Anti-thrombotic Drugs Revenue Market Share by Company in 2026
Figure 29. Global Anti-thrombotic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Anti-thrombotic Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Anti-thrombotic Drugs Sales Market Share by Country in 2026
Figure 40. Americas Anti-thrombotic Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Anti-thrombotic Drugs Sales Market Share by Region in 2026
Figure 48. APAC Anti-thrombotic Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Anti-thrombotic Drugs Sales Market Share by Country in 2026
Figure 59. Europe Anti-thrombotic Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Anti-thrombotic Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Anti-thrombotic Drugs in 2026
Figure 76. Manufacturing Process Analysis of Anti-thrombotic Drugs
Figure 77. Industry Chain Structure of Anti-thrombotic Drugs
Figure 78. Channels of Distribution
Figure 79. Global Anti-thrombotic Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Anti-thrombotic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Anti-thrombotic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Anti-thrombotic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Anti-thrombotic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Anti-thrombotic Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Anti-thrombotic Drugs
Figure 2. Anti-thrombotic Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Anti-thrombotic Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Anti-thrombotic Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Anti-thrombotic Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Anti-thrombotic Drugs Sales Market Share by Country/Region (2025)
Figure 10. Anti-thrombotic Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Heparins
Figure 12. Product Picture of Platelet Aggregation Inhibitors
Figure 13. Product Picture of Enzymes
Figure 14. Product Picture of Other
Figure 15. Global Anti-thrombotic Drugs Sales Market Share by Type in 2026
Figure 16. Global Anti-thrombotic Drugs Revenue Market Share by Type (2021-2026)
Figure 17. Anti-thrombotic Drugs Consumed in Hospital
Figure 18. Global Anti-thrombotic Drugs Market: Hospital (2021-2026) & (K Units)
Figure 19. Anti-thrombotic Drugs Consumed in Clinic
Figure 20. Global Anti-thrombotic Drugs Market: Clinic (2021-2026) & (K Units)
Figure 21. Anti-thrombotic Drugs Consumed in Other
Figure 22. Global Anti-thrombotic Drugs Market: Other (2021-2026) & (K Units)
Figure 23. Global Anti-thrombotic Drugs Sale Market Share by Application (2025)
Figure 24. Global Anti-thrombotic Drugs Revenue Market Share by Application in 2026
Figure 25. Anti-thrombotic Drugs Sales by Company in 2026 (K Units)
Figure 26. Global Anti-thrombotic Drugs Sales Market Share by Company in 2026
Figure 27. Anti-thrombotic Drugs Revenue by Company in 2026 ($ millions)
Figure 28. Global Anti-thrombotic Drugs Revenue Market Share by Company in 2026
Figure 29. Global Anti-thrombotic Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 30. Global Anti-thrombotic Drugs Revenue Market Share by Geographic Region in 2026
Figure 31. Americas Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 32. Americas Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 33. APAC Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 34. APAC Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 35. Europe Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 36. Europe Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 37. Middle East & Africa Anti-thrombotic Drugs Sales 2021-2026 (K Units)
Figure 38. Middle East & Africa Anti-thrombotic Drugs Revenue 2021-2026 ($ millions)
Figure 39. Americas Anti-thrombotic Drugs Sales Market Share by Country in 2026
Figure 40. Americas Anti-thrombotic Drugs Revenue Market Share by Country (2021-2026)
Figure 41. Americas Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 42. Americas Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 43. United States Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 44. Canada Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Mexico Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Brazil Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. APAC Anti-thrombotic Drugs Sales Market Share by Region in 2026
Figure 48. APAC Anti-thrombotic Drugs Revenue Market Share by Region (2021-2026)
Figure 49. APAC Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 50. APAC Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 51. China Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 52. Japan Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. South Korea Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. Southeast Asia Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. India Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. Australia Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. China Taiwan Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. Europe Anti-thrombotic Drugs Sales Market Share by Country in 2026
Figure 59. Europe Anti-thrombotic Drugs Revenue Market Share by Country (2021-2026)
Figure 60. Europe Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 61. Europe Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 62. Germany Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 63. France Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. UK Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. Italy Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Russia Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Middle East & Africa Anti-thrombotic Drugs Sales Market Share by Country (2021-2026)
Figure 68. Middle East & Africa Anti-thrombotic Drugs Sales Market Share by Type (2021-2026)
Figure 69. Middle East & Africa Anti-thrombotic Drugs Sales Market Share by Application (2021-2026)
Figure 70. Egypt Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 71. South Africa Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. Israel Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Turkey Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. GCC Countries Anti-thrombotic Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Anti-thrombotic Drugs in 2026
Figure 76. Manufacturing Process Analysis of Anti-thrombotic Drugs
Figure 77. Industry Chain Structure of Anti-thrombotic Drugs
Figure 78. Channels of Distribution
Figure 79. Global Anti-thrombotic Drugs Sales Market Forecast by Region (2027-2032)
Figure 80. Global Anti-thrombotic Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 81. Global Anti-thrombotic Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 82. Global Anti-thrombotic Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 83. Global Anti-thrombotic Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 84. Global Anti-thrombotic Drugs Revenue Market Share Forecast by Application (2027-2032)
